236 related articles for article (PubMed ID: 28655344)
1. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Baazaoui N; Iqbal K
Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
[TBL] [Abstract][Full Text] [Related]
2. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
3. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.
Bolognin S; Buffelli M; Puoliväli J; Iqbal K
Neurobiol Aging; 2014 Sep; 35(9):2134-46. PubMed ID: 24702821
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
7. Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice.
Wei W; Wang Y; Liu Y; Dai CL; Tung YC; Liu F; Iqbal K
Alzheimers Res Ther; 2020 Aug; 12(1):102. PubMed ID: 32854771
[TBL] [Abstract][Full Text] [Related]
8. A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2018; 62(3):1211-1218. PubMed ID: 29562539
[TBL] [Abstract][Full Text] [Related]
9. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.
Garcia P; Youssef I; Utvik JK; Florent-Béchard S; Barthélémy V; Malaplate-Armand C; Kriem B; Stenger C; Koziel V; Olivier JL; Escanye MC; Hanse M; Allouche A; Desbène C; Yen FT; Bjerkvig R; Oster T; Niclou SP; Pillot T
J Neurosci; 2010 Jun; 30(22):7516-27. PubMed ID: 20519526
[TBL] [Abstract][Full Text] [Related]
10. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
13. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
Baazaoui N; Flory M; Iqbal K
J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
[TBL] [Abstract][Full Text] [Related]
15. A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer's Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice.
Yu YZ; Liu S; Wang HC; Shi D; Xu Q; Zhou XW; Sun ZW; Huang PT
J Neuroimmune Pharmacol; 2016 Dec; 11(4):657-668. PubMed ID: 27147259
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.
Baazaoui N; Iqbal K
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291618
[TBL] [Abstract][Full Text] [Related]
17. An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide.
Bolognin S; Blanchard J; Wang X; Basurto-Islas G; Tung YC; Kohlbrenner E; Grundke-Iqbal I; Iqbal K
Acta Neuropathol; 2012 Jan; 123(1):133-51. PubMed ID: 22083255
[TBL] [Abstract][Full Text] [Related]
18. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
19. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
Kazim SF; Blanchard J; Bianchi R; Iqbal K
Sci Rep; 2017 Apr; 7():45561. PubMed ID: 28368015
[TBL] [Abstract][Full Text] [Related]
20. Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound.
Khatoon S; Chalbot S; Bolognin S; Puoliväli J; Iqbal K
J Alzheimers Dis; 2015; 47(3):557-64. PubMed ID: 26401692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
